中文| EN

代表论文

您目前的位置：院首页>首页 > 2012年

2012

2012年：
  1. Xuan Zhou, Dewei Shang, Tianlan Zhang, Liang Li,Tianyan Zhou*, Wei Lu* (2012) Modeling of Angiotensin II-Angiotensin-(1-7) Counterbalance in Disease Progression in Spontaneously Hypertensive Rats Treated With/Without Perindopril. Pharmacol Res. 66:177-184. (IF= 4.346)
  2. Xingang Li, Liang Li, Xipei Wang, Yupeng Ren, Tianyan Zhou*, Wei Lu* (2012)Application of Model-Based Methods to Characterize Exenatide-Loaded Double-Walled Microspheres: In Vivo Release, Pharmacokinetic/Pharmacodynamic Model, and In Vitro and In Vivo Correlation. J Pharm Sci. 101(10):3946-3961. (IF= 3.055)
  3. Jiaojiao Xu, Ye Chen, Liang Li, Zaiquan Li, Chenai Wang, Tianyan Zhou*, Wei Lu* (2012)An improved HPLC method for the quantitation of 3′-phosphoadenosine 5′-phosphate (PAP) to assay sulfotransferase enzyme activity in HepG2 cells.J Pharmaceut Biomed. 62:182-186. (IF= 2.967)
  4. Tianyan Zhou, Yue Chen, Chaoqun Huang, Guangping Chen (2012) Caffeine induction of sulfotransferases in rat liver and intestine. J Appl Toxicol.32:804-809. (IF= 2.478)
  5. Xiwei Ji, Ye Chen, Runtiao Li, Tianyan Zhou*, Wei Lu* (2012)A high-sensitivity LC-MS/MS method for determination of 4-methyl-piperazine-1-carbodithioc acid 3-cyano-3, 3-diphenylpropyl ester hydrochloride in rat plasma and its application to pharmacokinetics study. Biomed Chromatogr. 26:1196-1201.(IF= 1.966)
  6. Xingang Li, Liang Li, Xuan Zhou, Ye Chen, Yupeng Ren, Tianyan Zhou*, Wei Lu* (2012)Pharmacokinetic/pharmacodynamic studies for exenatide in diabetic rats. Acta Pharmacol Sin.33:1379-1386. (IF= 1.953)
  7. Liang Li, Zaiquan Li, Chenhui Deng, Miaoran Ning,; Hanqing Li, Shanshan Bi, Tianyan Zhou*, Wei Lu* (2012) Mechanism-based Pharmacokinetic/Pharmacodynamic Model for CYP3A1/2 Induction by Dexamethasone in Rats. Acta Pharmacol Sin.33:127-136. (IF= 1.953)
  8. Zhao S, Dai W, He B, Wang J, He Z, Zhang X*, Zhang Q*(2012). Monitoring the transport of polymeric micelles across MDCK cell monolayer and exploring related mechanisms. J Control Release. 2012 Mar 28;158(3):413-23. (IF=7.633)
  9. Zhao BX, Zhao Y, Huang Y, Luo LM, Song P, Wang X, Chen S, Yu KF, Zhang X*, Zhang Q(2012). The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel. Biomaterials. 2012 Mar;33(8):2508-20. (IF=7.604)
  10. ZZ Yang, ZZ Wang, K Wu, XR Qi*. Tissue Distribution and Pharmacodynamics of Rivastigmine after Intranasal and Intravenous Administration in Rats. Current Alzheimer Res. 2012, 9(3)：315-325.
  11. Shu-Wen Tong, Bai Xiang, Da-Wen Dong, Xian-Rong Qi*. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles. International Journal of Pharmaceutics 434 (2012): 413– 419.
  12. Nian-Qiu Shi, Wei Gao, Bai Xiang, Xian-Rong Qi*. Enhancing cellular uptake of activable cell-penetrating peptide–doxorubicin conjugate by enzymatic cleavage. International Journal of Nanomedicine 2012:7 1613–1621.
  13. Dai-Chao Cui,Wan-Liang Lu, Er-A Sa, Meng-Jie Gu, Xiao-Jing Lu, Tian-Yuan Fan* (2012) Poly(acrylic acid) microspheres loaded with lidocaine: Preparation and characterization for arterial embolization. Int J Pharm. 436: 527– 535. (IF 3.867)
  14. Chao Zhou, Daichao Cui, Yuan Zhang, Huiyan Yuan, Tianyuan Fan* (2012) Preparation and characterization of ketoprofen-loaded microspheres for embolization. J Mater Sci-Mater M. 23:409-418. (IF 2.48)
  15. Xue-Qing Wang, Qiang Zhang* (2012) pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs. European Journal of Pharmaceutics and Biopharmaceutics. 82 (2): 219-229. (IF 3.826)
  16. Xueqing Wang, Javed Iqbal, Deni Rahmat, Andreas Bernkop-Schnürch* (2012) Preactivated thiomers: Permeation enhancing properties. International Journal of Pharmaceutics. 438 (1-2): 217-224. (IF 3.458)
  17. Xingwei Chen, Xinru Li, Yanxia Zhou, Xiaoning Wang, Yanhui Zhang Yating Fan, Yanqing Huang, Yan Liu*.Chitosan-based Thermosensitive Hydrogel as a Promising Ocular Drug Delivery System: Preparation, Characterization and In Vivo Evaluation. Journal of Biomaterials Applications, 2012, 27(4): 391-402. (IF=2.64)
  18. Na Li, Xinru Li, Yanxia Zhou, Wenjing Li, Yong Zhao, Shujin Ma, Jinwen Li, Yajie Gao, Yan Liu*, Xinglin Wang, Dongdong Yin. The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier. Biomaterials, 2012,33(34):8881-8892. (IF=7.604)
  19. Guiling Li, Yating Fan, Chao Fan, Xinru Li, Xiaoning Wang, Mei Li, Yan Liu*. Tacrolimus-loaded ethosomes: Physicochemical characterization and in vivo evaluation. European Journal of Pharmaceutics and Biopharmaceutics, 2012, 82:49-57. (IF=3.826)
  20. Guiling Li, Yating Fan, Xinru Li, Xiaoning Wang, Yanfang Li, Yan Liu*, Mei Li. In vitro and in vivo evaluation of a simple microemulsion formulation for propofol. International Journal of Pharmaceutics, 2012, 425:53–61.(IF=3.458)
  21. Wenbing Dai, Tingyuan Yang, Yiguang Wang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, Qiang Zhang (2012) Peptide PHSCNK as an integrin α5β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma. Nanomed-nanotechnol. 8 (7): 1152–1161. (IF6.692)
  22. Wenbing Dai, Wu Jin, Junlin Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, You Wan, Qiang Zhang (2012) Spatiotemporally Controlled Co-delivery of Anti-vasculature Agent and Cytotoxic Drug by Octreotide-Modified Stealth Liposomes. Pharm Res. 29(10):2902–2911. (IF4.093)
  23. Zhaohui Wang, Yang Yu, Wenbing Dai, Jingkai Lu, Jingrong Cui, Hounan Wu, Lan Yuan, Hua Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, Qiang Zhang. (2012)The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer. Biomaterials, 33(33): 8451-8460. (IF:7.404)
  24. Zhaohui Wang, Yang Yu, Jie Ma, Haoran Zhang, Hua Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, Qiang Zhang. (2012) LyP-1 Modification To Enhance Delivery of Artemisinin or Fluorescent Probe Loaded Polymeric Micelles to Highly Metastatic Tumor and Its Lymphatics.Molecular Pharmaceutics, 9(9):2646-2657.(IF:4.782)
  25. Nan Zheng, Wenbing Dai, Wenwen Du, Haoran Zhang, Liandi Lei, Hua Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, JinmingGao, Qiang Zhang. (2012) A Novel Lanreotide-Encoded Micelle System Targets Paclitaxel to the Tumors with Overexpression of Somatostatin Receptors. Molecular Pharmaceutics, 9(5):1175-1188. (IF:4.782)
  26. Wenbing Dai, Tingyuan Yang, Yiguang Wang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, Qiang Zhang, (2012) Peptide PHSCNK as an integrin α5β1 antagonist targets stealth liposomesto integrin-overexpressing melanoma. Nanomedicine: Nanotechnology, Biology, and Medicine, 8 (7) 1152–1161 (IF:6.692)
  27. Yang Zhang, Hua Zhang , Xueqing Wang, Jiancheng Wang, Xuan Zhang, Qiang Zhang. (2012) The eradication of breast cancer and cancer stem cells using octreotidemodifiedpaclitaxel active targeting micelles and salinomycin passive targeting micelles. Biomaterials. 33:679-691. (IF:7.404)
  28. Wenbing Dai, Wu Jin,Junlin Zhang,Xueqing Wang,Jiancheng Wang,Xuan Zhang, You Wan,Qiang Zhang. (2012) Spatiotemporally Controlled Co-delivery of Anti-vasculatureAgent and Cytotoxic Drug by Octreotide-ModifiedStealth Liposomes. Pharm Res, 29(10):2902–2911.(IF:4.093)
  29. Liang Liang, Song-Wen Lin, Wenbin Dai, Jing-Kai Lu, Ting-Yuan Yang, Yu Xiang, Yang Zhang, Run-Tao Li*, Qiang Zhang*.(2012) Novel cathepsin B-sensitive paclitaxel conjugate: higher water solubility, better efficacy and lower toxicity.Journal of Controlled Release，160（3）:618-629. (IF:6.499)
  30. Shan Shan Zhao,Wenbing Dai, Bing He, JianchengWang, ZhongguiHe, XuanZhang*, QiangZhang* (2012) Monitoring the transport of polymeric micelles across MDCK cell monolayer and exploring related mechanisms.J Control Release. 158(3):413-23 (IF:6.499)
  31. Xue-Qing Wang, Qiang Zhang (2012) pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.European Journal of Pharmaceutics and Biopharmaceutics, 82(2): 219-229.(IF: 4.269)
  32. Tingyuan Yang, Yiguang Wang, Zaiquan Li, Wenbing Dai, Jie Yin, Liang Liang, Xue Ying, Shufeng Zhou, Jiancheng Wang, Xuan Zhang, Qiang Zhang. (2012) Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature. Nanomedicine: Nanotechnology, Biology, and Medicine, 8 (1) 81–92 (IF:6.692)
  33. Zhao ZX, Gao SY, Wang JC*, Chen CJ, Zhao EY, Hou WJ, Feng Q, Gao LY, Liu XY, Zhang LR*, Zhang Q. Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine(R15) triblock copolymer for siRNA delivery. Biomaterials. 2012,33(28):6793-807.
  34. Enyu Zhao, Zhixia Zhao, Jiancheng Wang*, Chunhui Yang,* Chengjun Chen, Lingyan Gao,Qiang Feng, Wenjie Hou, Mingyuan Gao* and Qiang Zhang. Surface engineering of gold nanoparticles for in vitro siRNA delivery. Nanoscale, 2012,4(16): 5102–5109.
  35. Xiao-Mei Tao, Jian-cheng Wang*, Jia-bao Wang, Qiang Feng, Shan-yun Gao, Liang-Ren Zhang , Qiang Zhang*. Enhanced anticancer activity of gemcitabine coupling with conjugated linoleic acid against human breast cancer in vitro and in vivo, European Journal of Pharmaceutics and Biopharmaceutics 2012,82(2):401-409

 

版权所有：北京大学药学院 地址：北京市海淀区学院路38号 邮编：100191 电话: 010-82805656;010-82802184 E-mail：yxdb@bjmu.edu.cn